Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-11 Purchase | 2023-04-11 6:59 pm | GT Biopharma Inc. | GTBP | Breen Michael Martin Executive Chairman/Interim CEO | 50,000 | $0.5 | $25,000 | 656,218 (Direct) | View |
| 2023-04-06 Purchase | 2023-04-10 5:26 pm | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 50,000 | $0.5 | $25,000 | 150,000 (Indirect) | View |
| 2020-11-16 Purchase | 2021-10-07 2:47 pm | GT Biopharma Inc. | GTBP | Wendel Bruce Director | 5,083 | $5.1739 | $26,299 | 402,655 (Direct) | View |
| 2020-12-21 Sale | 2020-12-23 4:24 pm | GT Biopharma Inc. | GTBP | Weldon Steven W Former Officer and Director Director | 183,700 | $0.34206 | $62,837 | 3,720,000 (Direct) | View |
| 2020-12-16 Sale | 2020-12-18 4:24 pm | GT Biopharma Inc. | GTBP | Weldon Steven W Former Officer and Director Director | 200,000 | $0.3025 | $60,500 | 3,903,700 (Direct) | View |
| 2020-12-11 Sale | 2020-12-15 5:40 pm | GT Biopharma Inc. | GTBP | Weldon Steven W Former Officer and Director Director | 396,300 | $0.28621 | $113,427 | 4,103,700 (Direct) | View |
| 2020-06-02 Sale | 2020-06-04 5:15 pm | GT Biopharma Inc. | GTBP | Cataldo Tony CEO 10% Owner | 4,234,320 | $0.001 | $4,234 | 6,500,000 (Direct) | View |
| 2020-05-13 Sale | 2020-05-14 1:40 pm | GT Biopharma Inc. | GTBP | Weldon Steven W CFO | 2,269,708 | $0.001 | $2,270 | 4,500,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-17 Option Award | 2024-10-21 9:13 pm | N/A 2034-10-16 | GT Biopharma Inc. | GTBP | URBAN ALAN LOUIS Chief Financial Officer | 23,335 | $0 | 23,335 (Direct) | View |
| 2023-08-11 Option Award | 2023-08-15 7:29 pm | N/A N/A | GT Biopharma Inc. | GTBP | Breen Michael Martin Executive Chairman/Interim CEO | 200,000 | $0.287 | 856,218 (Direct) | View |
| 2023-08-11 Option Award | 2023-08-15 7:26 pm | N/A N/A | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 200,000 | $0.287 | 750,000 (Direct) | View |
| 2023-08-11 Other | 2023-08-15 7:26 pm | N/A N/A | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 200,000 | $0.287 | 750,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 7:58 pm | N/A 2033-06-15 | GT Biopharma Inc. | GTBP | CASAMENTO CHARLES J Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-02-01 06:05 am | N/A 2033-01-26 | GT Biopharma Inc. | GTBP | Breen Michael Martin Exec Chairman and Interim CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-02-01 06:02 am | N/A 2033-01-26 | GT Biopharma Inc. | GTBP | Ohri Manu Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-02-01 06:02 am | N/A 2033-01-26 | GT Biopharma Inc. | GTBP | SHROTRIYA RAJESH C MD Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-02-01 06:01 am | N/A 2033-01-26 | GT Biopharma Inc. | GTBP | Wendel Bruce Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 9:48 pm | 2022-07-15 2032-07-14 | GT Biopharma Inc. | GTBP | Breen Michael Martin Exec. Chair. and Interim CEO | 328,058 | $0 | 656,218 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 9:46 pm | 2022-07-15 2032-07-14 | GT Biopharma Inc. | GTBP | SHROTRIYA RAJESH C MD Director | 461,476 | $0 | 461,476 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 9:46 pm | N/A 2032-07-14 | GT Biopharma Inc. | GTBP | URBAN ALAN LOUIS Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 9:44 pm | 2022-07-15 2032-07-14 | GT Biopharma Inc. | GTBP | Berk Gregory Pres. of R&D, CMO | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 9:44 pm | N/A 2032-07-14 | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 300,000 | $0 | 500,000 (Direct) | View |
| 2022-07-15 Other | 2022-07-19 9:44 pm | N/A N/A | GT Biopharma Inc. | GTBP | Ohri Manu CFO & Secretary | 100,000 | $0 | 500,000 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 9:42 pm | 2022-07-15 2032-07-14 | GT Biopharma Inc. | GTBP | Wendel Bruce Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-02-16 Option Award | 2022-02-14 5:10 pm | N/A 2031-02-15 | GT Biopharma Inc. | GTBP | Berk Gregory Director | 328,058 | $0 | 328,058 (Direct) | View |
| 2021-02-16 Option Award | 2022-02-14 4:13 pm | N/A 2031-02-15 | GT Biopharma Inc. | GTBP | SHROTRIYA RAJESH C MD Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-12-31 Option Award | 2022-02-14 4:09 pm | N/A 2031-12-31 | GT Biopharma Inc. | GTBP | Choy Gavin Acting Chief Financial Officer | 227,500 | $0 | 227,500 (Direct) | View |
| 2021-02-16 Option Award | 2021-11-12 12:01 pm | N/A 2031-02-15 | GT Biopharma Inc. | GTBP | Breen Michael Martin Director | 328,058 | $0 | 378,160 (Direct) | View |
| 2021-02-25 Conversion | 2021-11-12 12:01 pm | N/A N/A | GT Biopharma Inc. | GTBP | Breen Michael Martin Director | 50,102 | $3.4 | 378,160 (Direct) | View |
| 2021-02-25 Conversion | 2021-11-12 12:01 pm | 2018-09-07 N/A | GT Biopharma Inc. | GTBP | Breen Michael Martin Director | 130,000 | $0 | 378,160 (Direct) | View |
Ownership | 2021-11-12 12:01 pm | 2018-09-07 N/A | GT Biopharma Inc. | GTBP | Breen Michael Martin Director | 0 | $0 | 0 (Direct) | View |
| 2021-02-16 Option Award | 2021-10-07 2:47 pm | N/A 2031-02-15 | GT Biopharma Inc. | GTBP | Wendel Bruce Director | 397,572 | $0 | 402,655 (Direct) | View |